March 15th 2007
For men with prostate cancer, radiation seed implants may yield a better short-term side effect profile than surgery, but surgery may offer slightly better long-term outcomes, new research from French radiation oncologists indicates.
February 15th 2007
December 7th 2006
Botulinum may offer option in BPH, but results are equivocal
May 25th 2005Botulinum toxin A (Botox) injections show potential for providing a quick, easy, and safe treatment option for men with lower urinary tract symptoms related to BPH, but two small studies presented yesterday provided equivocal results regarding the efficacy of this investigational approach. U.S. researchers tested their 10-minute, ultrasound-guided technique in a two-part study. In the first part, 10 patients were injected with botulinum, 100 units, to assess safety, International Prostate Symptom Score, flow rates, and bother scores. In the second part, 30 patients received 200 units of botulinum in a sham-controlled, double-blind study, and sequential MRIs were taken pretreatment and at 1 and 3 months post-treatment to measure prostate volume.
Study shows feasibility of genitofemoral nerve grafts during RP
May 24th 2005Genitofemoral (GF) nerve grafting during radical retropubic prostatectomy can be performed safely with a low risk of postoperative morbidity and shows promising efficacy for returning erectile function after surgery involving wide nerve resection, according to the results of a retrospective study undertaken by urologists from Vanderbilt University, Nashville, TN.
Data offer more evidence of botulinum's benefit of OAB
May 15th 2005Istanbul, Turkey--Swiss data add to growing evidence that injecting botulinum toxin A (Botox) into the detrusor muscle is a safe and efficient treatment option in patients suffering from overactive bladder, particularly in cases that prove refractory to other more conventional treatment modalities, like anticholinergic agents and physiotherapy.
Estrogen receptor modulator prevents PCa in some men
May 1st 2005Orlando, FL--Testosterone's effect on the development and progression of BPH and prostate cancer is well known, but a group of University of Tennessee researchers has been focusing on testosterone's less frequently studied "partner in crime"—estrogen.
Combination treatment increases survival in high-risk PCa patients
January 6th 2005A combination of brachytherapy and external radiation plus androgen deprivation gives prostate cancer patients with high-risk disease a better chance of survival than patients treated with radiation alone, according to a study in the International Journal of Radiation Oncology*Biology*Physics (2005; 61:32-43).
Holmium laser reduces ureteral wall injury risks
May 10th 2004Trimedyne's OmniPulse Holmium:YAG Laser utilizes DoublePulse technology,which delivers the ablation effect of two laser pulses with the acousticeffect of one pulse when treating renal stones. It also reduces potentialrisks of ureteral wall injury compared with normal pulsed operation, thecompany says.
Botulinum toxin shows promising results in refractory OAB
May 10th 2004Known primarily for smoothing facial wrinkles, botulinumtoxin A (Botox) is gaining acceptance as a treatment option for refractoryoveractive and neurogenic bladder. The latest evidence comes from the Universityof Pittsburgh School of Medicine, where a 110-patient review of the off-labeluse of botulinum toxin for those indications produced promising resultsin terms of both safety and efficacy.
Anti-androgen shows benefit as adjuvant PCa therapy
May 1st 2004Vienna, Austria--The first analysis of the Early Prostate Cancer program-presented3 years ago at the European Association of Urology annual congress-revealedthat the anti-androgen bicalutamide (Casodex), 150 mg, cuts prostate cancerprogression risk almost in half in patients with localized or locally advanceddisease. A second analysis, presented at this year's meeting, confirmedthat the earlier finding holds true whether patients are treated with radicalprostatectomy, radiotherapy, or watchful waiting.
Laser lithotripsy under IV sedation appears safe, effective
April 30th 2003Chicago-Ureteroscopic laser lithotripsy can be performed safely and effectivelywith IV sedation, eliminating the need for general or spinal anesthesia,until now a principal downside to the procedure, a New York stone specialistreported at the AUA meeting yesterday.
Oxalate-degrading enzyme reduces stent encrustation
February 1st 2003Italy-Encrustation of urinary tract biomaterial remains a challenging problem for urologists. Devices such as urinary stents and catheters invariably become encrusted with calcium oxalate after long-term placement and are difficult to later remove.